Lyra Therapeutics Inc.

0.12
-0.00 (-0.08%)
At close: Apr 02, 2025, 3:59 PM
0.11
-2.80%
After-hours: Apr 02, 2025, 08:00 PM EDT

Lyra Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Revenue 1.53M 1.56M 1.36M 285K n/a n/a 1.24M
Cost of Revenue n/a n/a 1.07M 1M 95K 27K n/a
Gross Profit 1.53M 1.56M 296K -716K -95K -27K 1.24M
Operating Income -96.35M -67.12M -56.31M -43.62M -22.21M -16.52M -7.26M
Interest Income 2.95M 4.5M 1.04M 102K 82K 213K n/a
Pretax Income -93.4M -62.62M -55.27M -43.51M -22.13M -16.31M -6.03M
Net Income -93.44M -62.68M -55.28M -42.41M -22.05M -16.09M -6.03M
Selling & General & Admin 18.5M 19.06M 17.56M 14.21M 9.69M 4.49M 3.53M
Research & Development 43.77M 48.03M 38.8M 29.69M 12.52M 12.03M 4.97M
Other Expenses 35.62M n/a 1.32M n/a n/a n/a 1.19M
Operating Expenses 97.88M 68.68M 56.35M 43.9M 22.21M 16.52M 8.5M
Interest Expense n/a n/a 524K n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 97.88M 68.68M 56.35M 43.9M 22.21M 16.52M 8.5M
Income Tax 39K 59K 13K -1.1M -82K -213K -1.23M
Shares Outstanding (Basic) 65.11M 49.8M 30.24M 12.99M 8.59M 12.92M 6.27M
Shares Outstanding (Diluted) 65.11M 49.8M 30.24M 12.99M 8.59M 12.92M 6.27M
EPS (Basic) -1.43 -1.26 -1.83 -3.27 -2.57 -1.25 -0.96
EPS (Diluted) -1.43 -1.26 -1.83 -3.27 -2.57 -1.25 -0.96
EBITDA -60.26M -65.25M -53.92M -42.61M -22.11M -16.49M -7.18M
EBIT -60.73M -65.53M -54.99M -43.62M -22.21M -16.52M -7.26M
Depreciation & Amortization 471K 278K 1.07M 1M 95K 27K 82K